Overview

Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer

Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
To determine the molecular interaction in tumor samples between docetaxel and lonafarnib.
Phase:
Phase 1
Details
Lead Sponsor:
Emory University
Collaborators:
Aventis Pharmaceuticals
Schering-Plough
Treatments:
Docetaxel
Lonafarnib